Status:

COMPLETED

Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas

Lead Sponsor:

Pennington Biomedical Research Center

Collaborating Sponsors:

Lipothera

Conditions:

Lipoma

Eligibility:

All Genders

18-60 years

Phase:

PHASE1

PHASE2

Brief Summary

The purpose of this study is to test whether injected medications will increase the amount of fat released by a fat cell. We will compare prednisolone (a synthetic cortisone) combined with isoproteren...

Detailed Description

Lipomas are benign, non-cancerous fatty tumors that occur under the skin and make a bump that can be easily felt and often seen. The current treatment for lipomas is surgery. Isoproterenol, a medicati...

Eligibility Criteria

Inclusion

  • You are a man or a woman between the ages of 18-60, inclusive.
  • You have a body mass index (BMI) between 20 and less than 40 kg/m2. BMI is a number calculated from your height and weight.
  • You have a lipoma (a benign fatty tumor) that is 1 inch or more in diameter under the skin of your abdomen or on another area of your body that is easily accessible to study (such as the thigh).
  • You have not gained or lost more than 11 pounds in the last 3 months.
  • Your exercise routine has been stable for the last 3 months or you are sedentary. Sedentary means you do less than 60 minutes of exercise per week.

Exclusion

  • You have a history of heart or blood vessel disease.
  • Your blood pressure is above 140/90 mmHg.
  • You have type 1 diabetes.
  • You have a history of kidney or liver disease.
  • You have thyroid disease that has not been treated.
  • You are a smoker.
  • You use a Beta-2 (B2) adrenergic stimulator (a type of drug used to treat asthma), a beta adrenergic blocker (a type of drug used to treat blood pressure) or glucocorticoid medications (a type of drug used to treat immune system disease).
  • You have a problem with alcoholism or other substance abuse.
  • You are pregnant or breast feeding.

Key Trial Info

Start Date :

October 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2009

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT00624416

Start Date

October 1 2007

End Date

March 1 2009

Last Update

December 21 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pennington Biomedical Research Center

Baton Rouge, Louisiana, United States, 70808